Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe NIH grant/contract year 2016 is added to the study details, and the page revision is updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision tag was updated to v3.6.5, replacing v3.6.4. This appears to be a maintenance/version update rather than a change to study content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the page; visible study details appear unchanged.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page shows an updated revision to v3.6.3, indicating an update to the page framework.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page header's revision label was updated from v3.6.0 to v3.6.2, indicating an update to the underlying platform. This change does not modify the study details or other user-facing information.SummaryDifference0.0%

- Check97 days agoChange DetectedThe page now displays recruitment status as no longer recruiting, and new navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention/Treatment heading was added/renamed and the revision label updated to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.